Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
IMP3 encodes the human homolog of the yeast Imp3 protein. Additionally we are shipping IMP3 Proteins (8) and IMP3 Kits (1) and many more products for this protein.
Showing 10 out of 73 products:
Human Polyclonal IMP3 Primary Antibody for FACS, IHC (p) - ABIN653856
Li, Yan, Tang, Zhou, Fan, Li, Wang, Xia, Huang, Qiu, Peng: IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. in Annals of surgical oncology 2010
Show all 4 references for ABIN653856
Human Polyclonal IMP3 Primary Antibody for EIA, FACS - ABIN952891
Riener, Fritzsche, Clavien, Pestalozzi, Probst-Hensch, Jochum, Kristiansen: IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas. in Human pathology 2009
Show all 4 references for ABIN952891
Human Polyclonal IMP3 Primary Antibody for WB - ABIN2779134
Ma, Jin, Liu, Yang, Zheng, Zhang, Miao, Chen: [Comparison of 3 hand-carried ultrasound devices with comprehensive echocardiographic devices in elderly cardiac inpatient examinations]. in Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation 2008
Show all 2 references for ABIN2779134
Human Polyclonal IMP3 Primary Antibody for ELISA, WB - ABIN4325734
Walter, Prasad, Lu, Quinlan, Edmiston, Khan: IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. in Human pathology 2009
IMP-3 (show IGF2BP3 Antibodies) and its protein partners ILF3/NF90 (show MMP4 Antibodies) and PTBP1 (show PTBP1 Antibodies) bind to the 3'UTRs of the cyclin (show PCNA Antibodies) mRNAs and protect them from the translational repression induced by miRNA-dependent recruitment of AGO2 (show EIF2C2 Antibodies)/GW182 complex in human cancer cells.
S100P (show S100P Antibodies) achieved 96.4% sensitivity, 93.3% specificity, 98.2% PPV (show PPP6C Antibodies), 87.5% NPV and 95.8% total accuracy, while IMP3 (show IGF2BP3 Antibodies) achieved 91.2% sensitivity, 86.7% specificity, 96.2% PPV (show PPP6C Antibodies), 72.2% NPV and 90.3% total accuracy for pancreatic ductal adenocarcinoma (PDA).Both markers were sensitive and specific for diagnosis of PDA.
This study aimed to demonstrate the usefulness of mRNA expression levels of IMP3 (show IGF2BP3 Antibodies) in brush cytology specimens combined with cytology for the diagnosis of malignant biliary stricture
Tissue overexpression of IMP3 (show IGF2BP3 Antibodies) might be used as a predictor of advanced disease or lymph node metastasis, and is associated with poorer prognosis in gastric cancers.
EGF (show EGF Antibodies) stimulates IMP-3 (show IGF2BP3 Antibodies) expression.
IMP3 (show IGF2BP3 Antibodies) may play a certain role in hydatidiform moles progression, and it may serve as a prognostic biomarker for this disease.
Our results showed that IMP3 (show IGF2BP3 Antibodies) immunostaining has a higher sensitivity and specificity than mesothelin (show MSLN Antibodies) for the diagnosis of pancreatic ductal adenocarcinoma. IMP3 (show IGF2BP3 Antibodies) and mesothelin (show MSLN Antibodies) may be useful markers in distinguishing neoplastic from reactive lesions of the pancreas in instances where this is impossible by morphology alone in surgical pathology practice.
Our study clearly demonstrated differentiation-dependent expression of IMP3 (show IGF2BP3 Antibodies) in chondrosarcoma, and suggests IMP3 (show IGF2BP3 Antibodies) as a novel marker for differentiating problematic cases of enchondroma from well-differentiated chondrosarcomas
IMP3 (show IGF2BP3 Antibodies) directly interacts with ULBP2 (show ULBP2 Antibodies) mRNA, leading to ULBP2 (show ULBP2 Antibodies) transcript destabilization and reduced ULBP2 (show ULBP2 Antibodies) surface expression and indirectly downregulates MICB (show MICB Antibodies) with a mechanism functionally distinct from that of ULBP2 (show ULBP2 Antibodies).
IMP3 (show IGF2BP3 Antibodies) appears to play an important role in tumor invasion in patients with lung adenocarcinoma and may serve as a useful prognostic biomarker in these patients.
IGF2BP3 (show IGF2BP3 Antibodies) regulated transcripts via targeting elements within 3' untranslated regions (3'UTR (show UTS2R Antibodies))
Imp3 (show SPPL2A Antibodies) as a key regulator of stem-like tumorigenic characteristics in osteosarcoma cells
This gene encodes the human homolog of the yeast Imp3 protein. The protein localizes to the nucleoli and interacts with the U3 snoRNP complex. The protein contains an S4 domain.
U3 small nucleolar ribonucleoprotein protein IMP3
, IMP3, U3 small nucleolar ribonucleoprotein, homolog (yeast)
, U3 snoRNP protein 3 homolog
, U3 snoRNP protein IMP3
, IGF-II mRNA-binding protein 3
, IGF2 mRNA-binding protein 3
, VICKZ family member 3
, insulin-like growth factor 2 mRNA-binding protein 3
, insulin-like growth factor 2, binding protein 3